Reprogramming translation for rare disease therapy: challenges posed by large genes.

Pattnaik BR, Sahel JA

Open source

DOI
10.1038/s41392-026-02942-8
Published
2026 Aug 26
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-026-02942-8,
  title = {Reprogramming translation for rare disease therapy: challenges posed by large genes.},
  author = {Pattnaik BR and Sahel JA},
  year = {2026},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-026-02942-8},
  url = {https://doi.org/10.1038/s41392-026-02942-8}
}

RIS

TY  - JOUR
TI  - Reprogramming translation for rare disease therapy: challenges posed by large genes.
AU  - Pattnaik BR
AU  - Sahel JA
PY  - 2026
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-026-02942-8
UR  - https://doi.org/10.1038/s41392-026-02942-8
ER  -

APA

BR, P., & JA, S. (2026). Reprogramming translation for rare disease therapy: challenges posed by large genes.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-02942-8

Source records